Dermatitis
MONDO:0002406An inflammatory process affecting the skin. Signs include red rash, itching, and blister formation. Representative examples are contact dermatitis, atopic dermatitis, and seborrheic dermatitis.
Also known as: inflammation of skin, inflammation of the skin, inflammation of zone of skin, inflammatory skin disease, skin inflammation, zone of skin inflammation
1623 clinical trials for this condition and its sub-types, 65 tagged with Dermatitis itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Dermatitis
-
Atopic eczema 467 trials · 480 incl. sub-types
3 sub-types
- Allergic contact dermatitis 10 trials Sub-types →
- Allergic urticaria 3 trials · 5 incl. sub-types Sub-types →
- Allergic cutaneous vasculitis 1 trial
-
Psoriasis 379 trials
3 sub-types
- Pustular psoriasis 6 trials · 39 incl. sub-types Sub-types →
- Guttate psoriasis 2 trials
- Psoriasis 2 0 trials
-
Urticaria 28 trials · 164 incl. sub-types
14 sub-types
- Angioedema 19 trials · 66 incl. sub-types Sub-types →
- Idiopathic urticaria 0 trials · 66 incl. sub-types Sub-types →
- Chronic urticaria 12 trials · 20 incl. sub-types Sub-types →
- Physical urticaria 3 trials · 15 incl. sub-types Sub-types →
- Cold urticaria 10 trials
- Allergic urticaria 3 trials · 5 incl. sub-types Sub-types →
- Drug rash with eosinophilia and systemic symptoms 5 trials
- Cutaneous mastocytosis 1 trial Sub-types →
- Urticaria, aquagenic 1 trial
- Urticaria, familial localized heat 1 trial
- Melkersson-Rosenthal syndrome 0 trials
- Autoimmune urticaria 0 trials
- Papular urticaria 0 trials
- Pruritic urticarial papules and plaques of pregnancy 0 trials
-
Skin infection 12 trials · 152 incl. sub-types
14 sub-types
- Tinea infection 1 trial · 116 incl. sub-types Sub-types →
- Scabies 12 trials Sub-types →
- Demodex folliculitis 5 trials
- Impetigo 5 trials Sub-types →
- Infection by Trypanosoma gambiense 3 trials
- Erysipelas 1 trial
- Pthirus pubis infestation 0 trials
- Cercarial dermatitis 0 trials
- Cutaneous diphtheria 0 trials
- Furunculosis 0 trials
- Gonococcal keratitis 0 trials
- Herpes simplex dermatitis 0 trials
- Herpes zoster dermatitis 0 trials Sub-types →
- Sycosis barbae 0 trials
-
Vitiligo 100 trials
3 sub-types
- Generalized vitiligo 16 trials
- Alopecia universalis onychodystrophy vitiligo 0 trials
- Trichrome vitiligo 0 trials
-
Dermatomyositis 81 trials · 100 incl. sub-types
11 sub-types
- Juvenile dermatomyositis 41 trials
- Anti-MDA5 dermatomyositis 3 trials
- Clinically amyopathic dermatomyositis 1 trial · 2 incl. sub-types Sub-types →
- Adermatopathic dermatomyositis 0 trials
- Adult dermatomyositis 0 trials
- Anti-Mi2 dermatomyositis 0 trials
- Anti-NXP2 dermatomyositis 0 trials
- Anti-SAE dermatomyositis 0 trials
- Anti-TIF1 dermatomyositis 0 trials
- Classical dermatomyositis 0 trials
- Neonatal dermatomyositis 0 trials
-
Acne 91 trials
1 sub-type
- Adult acne 0 trials
-
Autoimmune bullous skin disease 7 trials · 55 incl. sub-types
11 sub-types
- Pemphigus 20 trials · 27 incl. sub-types Sub-types →
- Bullous pemphigoid 18 trials
- Mucous membrane pemphigoid 5 trials · 9 incl. sub-types Sub-types →
- Acquired epidermolysis bullosa 3 trials
- Dermatitis herpetiformis 1 trial Sub-types →
- Pemphigoid 1 trial
- IgA pemphigus 0 trials
- Anti-p200 pemphigoid 0 trials
- Linear IgA Dermatosis 0 trials
- Paraneoplastic pemphigus 0 trials
- Subcorneal pustular dermatosis 0 trials
-
Lichen planus 19 trials · 47 incl. sub-types
11 sub-types
- Lichen planus, oral 30 trials
- Lichen planus pigmentosus 2 trials
- Atrophic lichen planus 1 trial
- Hypertrophic lichen planus 1 trial
- Actinic lichen planus 0 trials
- Annular atrophic lichen planus 0 trials
- Annular lichen planus 0 trials
- Bullous lichen planus 0 trials
- Lichen planus pemphigoides 0 trials
- Lichen planus, familial 0 trials
- Linear lichen planus 0 trials
-
Radiodermatitis 37 trials · 42 incl. sub-types
1 sub-type
- Photosensitivity disease 4 trials · 5 incl. sub-types Sub-types →
-
Contact dermatitis 9 trials · 24 incl. sub-types
4 sub-types
- Allergic contact dermatitis 10 trials Sub-types →
- Irritant dermatitis 9 trials Sub-types →
- Contact dermatitis due to nickel 1 trial
- Occupational dermatitis 1 trial
-
Lichen sclerosus et atrophicus 10 trials · 20 incl. sub-types
1 sub-type
- Vulvar lichen sclerosus 15 trials
-
Seborrheic dermatitis 15 trials
1 sub-type
- Seborrheic infantile dermatitis 0 trials
-
Neurodermatitis 10 trials
-
Folliculitis 1 trial · 8 incl. sub-types
4 sub-types
- Demodex folliculitis 5 trials
- Acne keloid 1 trial
- Eosinophilic pustular folliculitis 1 trial Sub-types →
- Sycosis barbae 0 trials
-
Neurotic excoriation 5 trials
-
Cutaneous vasculitis 4 trials · 5 incl. sub-types
1 sub-type
- Allergic cutaneous vasculitis 1 trial
-
Acanthosis nigricans 4 trials
2 sub-types
-
Acneiform dermatitis 4 trials
-
Hydroa vacciniforme 2 trials
1 sub-type
- Hydroa vacciniforme, familial 0 trials
-
Acrodermatitis 0 trials · 2 incl. sub-types
1 sub-type
- Acrodermatitis chronica atrophicans 2 trials
-
Exfoliative dermatitis 1 trial
-
Granuloma annulare 1 trial
-
Lipodermatosclerosis 1 trial
-
Parapsoriasis 0 trials · 1 incl. sub-types
3 sub-types
- Pityriasis lichenoides 1 trial Sub-types →
- Large plaque parapsoriasis 0 trials
- Small plaque parapsoriasis 0 trials
-
Porphyria cutanea tarda 0 trials · 1 incl. sub-types
3 sub-types
- Familial porphyria cutanea tarda 1 trial
- Hepatoerythropoietic porphyria 0 trials
- Sporadic porphyria cutanea tarda 0 trials
-
Dermatosis papulosa nigra 0 trials
-
Food dermatitis 0 trials
-
Granulomatous dermatitis 0 trials
-
Intertrigo 0 trials
-
Pityriasis rosea 0 trials
-
Spongiotic dermatitis 0 trials
Most studied deeper sub-types
-
New eczema drug shows promise for kids in Late-Stage trial
Disease control Recruiting nowThis study tests whether abrocitinib, a liquid medicine, can improve moderate-to-severe eczema in children aged 6 to 12. About 150 kids will be randomly assigned to receive either the drug or a placebo for 16 weeks. The goal is to see if the medicine clears the skin and reduces i…
Phase 3 • Sponsor: Pfizer • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Can a new injection calm severe eczema when creams fall short?
Disease control Recruiting nowThis study tests whether an investigational drug called tilrekimig, given as injections alongside medicated creams or ointments, can improve moderate-to-severe eczema (atopic dermatitis) in people aged 12 and older. Participants will be randomly assigned to receive either tilreki…
Phase 3 • Sponsor: Pfizer • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
New eczema drug shows promise in Mid-Stage trial
Disease control Recruiting nowThis study tests a new medication called camoteskimab for adults with moderate-to-severe atopic dermatitis (eczema). About 280 participants will receive either the drug or a placebo to see if it reduces skin redness, thickness, and itching over 24 weeks. The goal is to find a saf…
Phase 2 • Sponsor: Apollo Therapeutics Ltd • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
New shot could help eczema sufferers who Don't respond to steroids
Disease control Recruiting nowThis Phase 3 study tests whether lebrikizumab, an injectable drug, can safely and effectively treat nummular eczema in adults who haven't gotten enough relief from topical steroids or can't use them. About 270 participants will receive either lebrikizumab or a placebo injection. …
Phase 3 • Sponsor: Almirall, S.A. • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
New eczema drug shows promise in Mid-Stage trial
Disease control Recruiting nowThis study tests whether IMG-007 can safely reduce eczema symptoms like itching and redness in adults with moderate-to-severe disease who haven't responded well to topical treatments. About 405 participants will receive either the drug or a placebo, and researchers will measure s…
Phase 2 • Sponsor: Inmagene LLC • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Can a sticky film shield breast cancer patients from radiation burns in tropical heat?
Disease control Recruiting nowThis trial tests whether a silicone film called Mepitel Film can prevent radiation dermatitis — painful skin irritation — in breast cancer patients undergoing radiation therapy in Singapore's hot and humid weather. About 60 adults who have had breast cancer surgery and are schedu…
Sponsor: National University Hospital, Singapore • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
New daily pill shows promise for controlling stubborn eczema in real life
Disease control Recruiting nowThis study is tracking 183 adults with moderate-to-severe atopic dermatitis (eczema) who are taking abrocitinib, a daily tablet. Researchers want to see how well the drug works in real-life settings, not just in controlled clinical trials. Participants will be followed for 24 mon…
Sponsor: Pfizer • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
New eczema drug enters first human trials
Disease control Recruiting nowThis study is the first time REGN20423 is being tested in humans. It will enroll 144 adults, first healthy volunteers and then people with atopic dermatitis (eczema). The goal is to check safety, side effects, how the drug moves through the body, and whether it helps eczema sympt…
Phase 1 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
New hope for eczema sufferers: experimental drug GHZ339 enters Mid-Stage trial
Symptom relief Recruiting nowThis Phase 2 trial is testing an experimental drug called GHZ339 in 224 adults with moderate to severe atopic dermatitis (eczema). Participants will receive either the drug or a placebo, and researchers will measure changes in eczema severity using the EASI score at 16 weeks. The…
Phase 2 • Sponsor: Novartis Pharmaceuticals • Aim: Symptom relief
Last updated Aug 21, 2026 00:00 UTC
-
Probiotic drink may soothe menopause skin woes
Symptom relief Recruiting nowThis study tests whether a daily probiotic drink can improve immune function and reduce skin inflammation in women aged 40-60 going through menopause. Participants will drink either a probiotic or a plain milk drink for 8 weeks. Researchers will measure immune aging, inflammation…
Sponsor: King's College London • Aim: Symptom relief
Last updated Jun 27, 2026 12:30 UTC
-
New eczema cream studied in kids and adults – could reduce steroid use?
Symptom relief Recruiting nowThis study is testing a cream called RV4421B-EV0407, a medical device already sold in some countries, for mild to moderate atopic dermatitis (eczema). It includes 105 participants from 3 months old to adults, with diverse skin types. The cream is used alone or with steroid creams…
Sponsor: Pierre Fabre Dermo Cosmetique • Aim: Symptom relief
Last updated Jun 27, 2026 12:28 UTC
-
Hypnosis for eczema in kids: could it ease the itch?
Symptom relief Recruiting nowThis pilot study tests whether hypnosis can help children aged 8 to 17 with atopic dermatitis (eczema). The experimental group will learn a 'superhero costume' hypnosis technique and practice self-hypnosis at home. The study only aims to see if a larger trial is possible, not to …
Sponsor: Centre Hospitalier Universitaire de la Réunion • Aim: Symptom relief
Last updated Jun 26, 2026 15:39 UTC
-
Scientists probe how eczema drugs alter skin microbes
Knowledge-focused Recruiting nowThis study examines how common eczema treatments, including antibiotics and bleach baths, change the types and amounts of bacteria on the skin. Researchers will compare people with eczema to healthy volunteers. The goal is to understand the skin microbiome better, not to test a n…
Phase 2 • Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
New dermatitis drug candidate begins first human safety tests
Knowledge-focused Recruiting nowThis early-stage study tests whether a single dose of the experimental drug SHR-1894 is safe and how it moves through the body. It involves 40 healthy adults aged 18 to 45. No treatment is given; the goal is to gather safety information before testing in patients with dermatitis.
Phase 1 • Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:03 UTC
-
Massive study tracks 1,000 people to unlock secrets of eczema remission
Knowledge-focused Recruiting nowThis long-term study follows 1,000 people with eczema and related allergies, plus healthy volunteers, to see what factors help the disease go into remission. Researchers will collect medical and lifestyle data to find patterns and possible biomarkers. The goal is to better unders…
Sponsor: University of Zurich • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:02 UTC